You just read:

Foresee Announces Successful Completion of Scientific Advice Discussions with German Federal Institute for Drugs and Medical Devices (BfArM) for FP-001 LMIS 50 mg

News provided by

Foresee Pharmaceuticals Co., Ltd.

Feb 06, 2017, 06:59 ET